MTAP and urinary bladder cancer: The staining conditions had been titrated by using a TMA composed of 20 wild-type cells and 20 heterozygously and 20 homozygously MTAP-deleted bladder cancers to obtain maximal staining intensity in wild-type cells while retaining a complete absence of background staining in MTAP-deficient cancers [21].